- Home
- CPIX vs INCR Comparison
CPIX vs INCR Comparison
Compare CPIX & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- INCR
- Stock Information
- Founded
- CPIX 1999
- INCR 1994
- Country
- CPIX United States
- INCR Israel
- Employees
- CPIX N/A
- INCR N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- CPIX Health Care
- INCR Health Care
- Exchange
- CPIX Nasdaq
- INCR Nasdaq
- Market Cap
- CPIX 68.7M
- INCR 76.7M
- IPO Year
- CPIX 2009
- INCR N/A
- Fundamental
- Price
- CPIX $5.28
- INCR $1.57
- Analyst Decision
- CPIX
- INCR
- Analyst Count
- CPIX 0
- INCR 0
- Target Price
- CPIX N/A
- INCR N/A
- AVG Volume (30 Days)
- CPIX 38.4K
- INCR 8.6K
- Earning Date
- CPIX 05-06-2025
- INCR 05-01-2025
- Dividend Yield
- CPIX N/A
- INCR N/A
- EPS Growth
- CPIX N/A
- INCR N/A
- EPS
- CPIX N/A
- INCR N/A
- Revenue
- CPIX $41,083,299.00
- INCR $65,575,323.00
- Revenue This Year
- CPIX N/A
- INCR $69.54
- Revenue Next Year
- CPIX N/A
- INCR $41.75
- P/E Ratio
- CPIX N/A
- INCR N/A
- Revenue Growth
- CPIX 5.82
- INCR N/A
- 52 Week Low
- CPIX $1.04
- INCR $1.17
- 52 Week High
- CPIX $7.25
- INCR $3.28
- Technical
- Relative Strength Index (RSI)
- CPIX 53.74
- INCR 55.03
- Support Level
- CPIX $4.81
- INCR $1.51
- Resistance Level
- CPIX $6.21
- INCR $1.59
- Average True Range (ATR)
- CPIX 0.50
- INCR 0.05
- MACD
- CPIX -0.00
- INCR -0.00
- Stochastic Oscillator
- CPIX 38.00
- INCR 55.63
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.